GRDN
Get informed when a big investor buys or sells
+ FollowUndervalued by 54.8% based on the discounted cash flow analysis.
| Market cap | $2.35 Billion |
|---|---|
| Enterprise Value | $2.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.79 |
| Beta | 0.1 |
| Outstanding Shares | 63,327,000 |
| P/E Ratio | 35.3 |
|---|---|
| PEG | 24.82 |
| Price to Sales | 1.74 |
| Price to Book Ratio | 10.03 |
| Enterprise Value to Revenue | 1.55 |
| Enterprise Value to EBIT | 20.49 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 6,600▼ 83.50% |
Holdings and activity of institutional investors.
| Ownership % | 44.72%▲ 13.23% |
|---|---|
| Total Invested | $1.07B▲ 77.66% |
| Investors Holding | 172▲ 42.00% |
No data
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug ...